ARTICLE | Company News
Kereos, The Dow Chemical Co. deal
September 27, 2004 7:00 AM UTC
DOW granted Kereos exclusive commercialization rights to chelating molecules and chelate technology that Kereos will incorporate into its cancer and cardiovascular imaging agents, KI-0001 and KI-0002,...